Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Seizures and multiple sclerosis in Chinese patients: A clinical and magnetic resonance imaging study.
Foot placement patterns of female rollator users with multiple sclerosis in the community.
Bevacizumab Diminishes Experimental Autoimmune Encephalomyelitis by Inhibiting Spinal Cord Angiogenesis and Reducing Peripheral T-Cell Responses.
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
Use of a Time-of-Flight Camera With an Omek Beckon™ Framework to Analyze, Evaluate and Correct in Real Time the Verticality of Multiple Sclerosis Patients during Exercise.
Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.
Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review.
Outer retinal changes following acute optic neuritis.
Oligodendrocyte Precursor Cell-Intrinsic Effect of Rheb1 Controls Differentiation and Mediates mTORC1-Dependent Myelination in Brain.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
Vm24, a Natural Immunosuppressant Peptide Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells.
[Non-medicinal treatments of spasticity in multiple sclerosis].
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
Mitochondrial dysfunction in central nervous system white matter disorders.
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
Multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort.
Audit on intravenous immunoglobulin (ivig) use in aberdeen royal infirmary neurology department according to 2005 association of british neurologists (abn) guidelines.
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
Combined use of pharmacophoric models together with drug metabolism and genotoxicity "in silico" studies in the hit finding process.
Clinical predictors of an optimal response to natalizumab in multiple sclerosis.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.

Pages